EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

TRENDS IN EPIDEMIOLOGICAL ASPECTS OF LYME DISEASE WITH DOMESTIC AND EXOTIC INFECTIONS IN REPUBLIC OF KOREA, 2011-2017

Myeong-Jin Lee, Young-Hwan Kwon and Won-Chang Lee*

ABSTRACT

Background and Methods: This study focuses on a quantitative analysis of the epidemiological aspects of Lyme diseases (LD) with domestic and exotic infections in Republic of Korea (ROK). A total of 96 cases including domestic and exotic infections were 54 and 42 infections from 2011 to 2017. Especially, a total of 42 cases of imported exotic LD notifications were introduced from endemic foreign countries. The raw data obtained from the Korea Center for Disease Control and Prevention (KCDC). Results: Nationwide, the cumulative incidence rate (CIR) of LD was 0.027 per 100,000 populations; the CIR of LD with domestic and exotic cases was 0.015 and 0.033 per 100,000 populations, respectively. When compared, the CIR of domestic cases of LD was much lower than that in exotic cases (p<0.01). In addition, the exotic-to-domestic morbidity ratio (EDCR) was 0.78. During the same period, a CIR of LD in metropolitan area of Seoul (0.044) was higher than that of counties (0.023) in ROK (p<0.05). In the total case-fatality rate of LD was 1.04 %. On the other hands, our results also show that the male-to-female morbidity ratio (MFMR) was 0.66. More women was infected with LD than men (p<0.05). Individuals aged 40-59 years were most infected than those of other ages (42.7%, p<0.01). About four-fifths of reported LD cases occurred between June and November in year. Most imported exotic LD cases were associated with in Americas region (22 cases or 52.4% of total cases). The number of reported cases with LD has been increasing since from 2011 up to now. Conclusion: To prevent LD infections, greater attention should be paid to individuals who are the planning to presumptive areas.

Keywords: Domestic and Exotic LD, CIR, epidemic aspects, presumptive origins.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2024 issue has been successfully launched on NOVEMBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here